Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp K Haber

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Discovery Medicine|February 14, 2020
Translating cancer genomics for precision oncology in biliary tract cancersPhilipp K Haber, Daniela Sia
Chirurgie (Heidelberg, Germany)|December 10, 2024
[Cholangiocarcinomas]Wenzel Schöning, Philipp K Haber, Johann Pratschke
JHEP Reports : Innovation in Hepatology|March 5, 2021
Cell of origin in biliary tract cancers and clinical implicationsAgrin Moeini, Philipp K Haber, Daniela Sia
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2021
Atezolizumab plus Bevacizumab: A Novel Breakthrough in Hepatocellular CarcinomaFlorian Castet, Catherine E Willoughby, Philipp K Haber, et al.
Turkish Journal of Surgery|July 22, 2024
Integrating the new systemic treatment landscape and surgical therapy in hepatocellular carcinomaPhilipp K Haber, Felix Krenzien, Kaya Sarıbeyoğlu, et al.
Hypertension (Dallas, Tex. : 1979)|January 22, 2014
Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitroPhilipp K Haber, Minghao Ye, Jan Wysocki, et al.
Nature Reviews. Gastroenterology & Hepatology|January 29, 2021
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinomaJosep M Llovet, Thierry De Baere, Laura Kulik, et al.
Hepatology Communications|May 19, 2023
Biliary microbial patterns in primary sclerosing cholangitis are linked to poorer transplant-free survivalBurcin Özdirik, Maria Scherf, Ana Brumercek, et al.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|November 1, 2019
Laparoscopic Versus Open Liver Resection for Benign Tumors and Lesions: A Case Matched Study with Propensity Score MatchingSimon Wabitsch, Anika Kästner, Philipp K Haber, et al.
Langenbeck'S Archives of Surgery|November 17, 2021
Safety of intermittent Pringle maneuver during minimally invasive liver resection in patients with hepatocellular carcinoma with and without cirrhosisSantiago A Ortiz Galindo, Philipp K Haber, Christian Benzing, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Discovery Medicine|February 14, 2020
Translating cancer genomics for precision oncology in biliary tract cancersPhilipp K Haber, Daniela Sia
Chirurgie (Heidelberg, Germany)|December 10, 2024
[Cholangiocarcinomas]Wenzel Schöning, Philipp K Haber, Johann Pratschke
JHEP Reports : Innovation in Hepatology|March 5, 2021
Cell of origin in biliary tract cancers and clinical implicationsAgrin Moeini, Philipp K Haber, Daniela Sia
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2021
Atezolizumab plus Bevacizumab: A Novel Breakthrough in Hepatocellular CarcinomaFlorian Castet, Catherine E Willoughby, Philipp K Haber, et al.
Turkish Journal of Surgery|July 22, 2024
Integrating the new systemic treatment landscape and surgical therapy in hepatocellular carcinomaPhilipp K Haber, Felix Krenzien, Kaya Sarıbeyoğlu, et al.
Hypertension (Dallas, Tex. : 1979)|January 22, 2014
Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitroPhilipp K Haber, Minghao Ye, Jan Wysocki, et al.
Nature Reviews. Gastroenterology & Hepatology|January 29, 2021
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinomaJosep M Llovet, Thierry De Baere, Laura Kulik, et al.
Hepatology Communications|May 19, 2023
Biliary microbial patterns in primary sclerosing cholangitis are linked to poorer transplant-free survivalBurcin Özdirik, Maria Scherf, Ana Brumercek, et al.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|November 1, 2019
Laparoscopic Versus Open Liver Resection for Benign Tumors and Lesions: A Case Matched Study with Propensity Score MatchingSimon Wabitsch, Anika Kästner, Philipp K Haber, et al.
Langenbeck'S Archives of Surgery|November 17, 2021
Safety of intermittent Pringle maneuver during minimally invasive liver resection in patients with hepatocellular carcinoma with and without cirrhosisSantiago A Ortiz Galindo, Philipp K Haber, Christian Benzing, et al.
Pageof 3